Literature DB >> 16775106

Ischaemic preconditioning effect of prodromal angina pectoris is lost in patients with prior myocardial infarction.

M Ishihara, I Inoue, T Kawagoe, Y Shimatani, S Kurisu, T Hata, Y Nakama, Y Kijima, E Kagawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16775106      PMCID： PMC1860705          DOI： 10.1136/hrt.2005.066589

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis.

Authors:  M Ishihara; H Sato; H Tateishi; T Kawagoe; Y Shimatani; S Kurisu; K Sakai; K Ueda
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

2.  Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

Authors:  T Miki; T Miura; A Tsuchida; A Nakano; T Hasegawa; T Fukuma; K Shimamoto
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

3.  Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction.

Authors:  M Ishihara; H Sato; H Tateishi; T Kawagoe; Y Shimatani; K Ueda; K Noma; A Yumoto; K Nishioka
Journal:  Am Heart J       Date:  2000-05       Impact factor: 4.749

4.  Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction.

Authors:  M Ishihara; I Inoue; T Kawagoe; Y Shimatani; S Kurisu; K Nishioka; Y Kouno; T Umemura; S Nakamura; H Sato
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

5.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690
  5 in total
  2 in total

Review 1.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

Review 2.  Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.

Authors:  Tetsuji Miura; Tatsuya Sato; Toshiyuki Yano; Akira Takaguri; Takayuki Miki; Noritsugu Tohse; Keitaro Nishizawa
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.